Annual accounts receivable:
$202.66M-$3.90M(-1.89%)Summary
- As of today (June 11, 2025), HAE annual accounts receivable is $202.66 million, with the most recent change of -$3.90 million (-1.89%) on March 29, 2025.
- During the last 3 years, HAE annual accounts receivable has risen by +$43.28 million (+27.16%).
- HAE annual accounts receivable is now -1.89% below its all-time high of $206.56 million, reached on March 31, 2024.
Performance
HAE Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$202.66M-$9.29M(-4.38%)Summary
- As of today (June 11, 2025), HAE quarterly accounts receivable is $202.66 million, with the most recent change of -$9.29 million (-4.38%) on March 1, 2025.
- Over the past year, HAE quarterly accounts receivable has dropped by -$3.90 million (-1.89%).
- HAE quarterly accounts receivable is now -5.09% below its all-time high of $213.53 million, reached on September 28, 2024.
Performance
HAE Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
HAE Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.9% | -1.9% |
| 3 y3 years | +27.2% | +27.2% |
| 5 y5 years | +22.7% | +22.7% |
HAE Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.9% | +27.2% | -5.1% | +38.4% |
| 5 y | 5-year | -1.9% | +58.9% | -5.1% | +58.9% |
| alltime | all time | -1.9% | +242.7% | -5.1% | +242.7% |
HAE Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $202.66M(-1.9%) | - |
| Mar 2025 | - | $202.66M(-4.4%) |
| Dec 2024 | - | $211.95M(-0.7%) |
| Sep 2024 | - | $213.53M(+6.0%) |
| Jun 2024 | - | $201.49M(-2.5%) |
| Mar 2024 | $206.56M(+15.3%) | - |
| Mar 2024 | - | $206.56M(-2.4%) |
| Dec 2023 | - | $211.61M(+21.4%) |
| Sep 2023 | - | $174.25M(-1.6%) |
| Jun 2023 | - | $177.12M(-1.1%) |
| Mar 2023 | $179.14M(+12.4%) | $179.14M(-1.1%) |
| Dec 2022 | - | $181.10M(+5.6%) |
| Sep 2022 | - | $171.53M(+17.1%) |
| Jun 2022 | - | $146.46M(-8.1%) |
| Mar 2022 | $159.38M(+24.9%) | $159.38M(+2.8%) |
| Dec 2021 | - | $154.98M(+9.7%) |
| Sep 2021 | - | $141.31M(+6.3%) |
| Jun 2021 | - | $132.91M(+4.2%) |
| Mar 2021 | $127.56M(-22.8%) | $127.56M(-13.2%) |
| Dec 2020 | - | $146.94M(+3.8%) |
| Sep 2020 | - | $141.53M(+0.3%) |
| Jun 2020 | - | $141.09M(-14.6%) |
| Mar 2020 | $165.21M(-10.7%) | $165.21M(-3.2%) |
| Dec 2019 | - | $170.75M(-3.3%) |
| Sep 2019 | - | $176.53M(+8.1%) |
| Jun 2019 | - | $163.34M(-11.7%) |
| Mar 2019 | $185.03M(+22.4%) | $185.03M(+10.4%) |
| Dec 2018 | - | $167.64M(+3.7%) |
| Sep 2018 | - | $161.59M(+6.8%) |
| Jun 2018 | - | $151.34M(+0.1%) |
| Mar 2018 | $151.23M(-1.0%) | $151.23M(+3.1%) |
| Dec 2017 | - | $146.72M(+2.1%) |
| Sep 2017 | - | $143.69M(-5.2%) |
| Jun 2017 | - | $151.51M(-0.8%) |
| Mar 2017 | $152.68M(-2.8%) | $152.68M(+1.4%) |
| Dec 2016 | - | $150.56M(-0.7%) |
| Sep 2016 | - | $151.60M(+1.3%) |
| Jun 2016 | - | $149.67M(-4.7%) |
| Mar 2016 | $157.09M(+7.7%) | $157.09M(+5.6%) |
| Dec 2015 | - | $148.77M(+2.3%) |
| Sep 2015 | - | $145.41M(+4.5%) |
| Jun 2015 | - | $139.10M(-4.6%) |
| Mar 2015 | $145.83M(-11.4%) | $145.83M(+1.5%) |
| Dec 2014 | - | $143.63M(-4.9%) |
| Sep 2014 | - | $151.06M(-3.6%) |
| Jun 2014 | - | $156.73M(-4.8%) |
| Mar 2014 | $164.60M(-3.2%) | $164.60M(+10.0%) |
| Dec 2013 | - | $149.59M(-7.7%) |
| Sep 2013 | - | $162.08M(+3.9%) |
| Jun 2013 | - | $155.96M(-8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | $170.11M(+25.6%) | $170.11M(+1.7%) |
| Dec 2012 | - | $167.35M(+5.8%) |
| Sep 2012 | - | $158.18M(+25.4%) |
| Jun 2012 | - | $126.13M(-6.9%) |
| Mar 2012 | $135.46M(+6.5%) | $135.46M(+6.3%) |
| Dec 2011 | - | $127.44M(-1.4%) |
| Sep 2011 | - | $129.24M(+7.0%) |
| Jun 2011 | - | $120.76M(-5.0%) |
| Mar 2011 | $127.17M(+7.2%) | $127.17M(+5.6%) |
| Dec 2010 | - | $120.37M(-1.1%) |
| Sep 2010 | - | $121.77M(+6.0%) |
| Jun 2010 | - | $114.83M(-3.2%) |
| Mar 2010 | $118.58M(+4.4%) | $118.58M(+3.4%) |
| Dec 2009 | - | $114.73M(-3.3%) |
| Sep 2009 | - | $118.67M(+3.9%) |
| Jun 2009 | - | $114.16M(+0.5%) |
| Mar 2009 | $113.60M(-5.5%) | $113.60M(-8.8%) |
| Dec 2008 | - | $124.58M(+1.7%) |
| Sep 2008 | - | $122.50M(-4.2%) |
| Jun 2008 | - | $127.93M(+6.4%) |
| Mar 2008 | $120.25M(+30.9%) | $120.25M(+10.5%) |
| Dec 2007 | - | $108.81M(+7.8%) |
| Sep 2007 | - | $100.90M(+9.8%) |
| Jun 2007 | - | $91.92M(+0.1%) |
| Mar 2007 | $91.83M(+5.7%) | $91.83M(+6.8%) |
| Dec 2006 | - | $85.99M(+2.4%) |
| Sep 2006 | - | $84.00M(-5.9%) |
| Jun 2006 | - | $89.28M(+2.7%) |
| Mar 2006 | $86.90M(+7.7%) | $86.90M(+0.7%) |
| Dec 2005 | - | $86.26M(+3.4%) |
| Sep 2005 | - | $83.41M(-0.3%) |
| Jun 2005 | - | $83.63M(+3.6%) |
| Mar 2005 | $80.72M(-2.3%) | $80.72M(-7.8%) |
| Dec 2004 | - | $87.58M(+5.1%) |
| Sep 2004 | - | $83.35M(-0.8%) |
| Jun 2004 | - | $84.05M(+1.7%) |
| Mar 2004 | $82.64M(+5.2%) | $82.64M(-2.1%) |
| Dec 2003 | - | $84.40M(+0.3%) |
| Sep 2003 | - | $84.16M(-0.2%) |
| Jun 2003 | - | $84.33M(+7.3%) |
| Mar 2003 | $78.58M(+23.3%) | $78.58M(-0.8%) |
| Dec 2002 | - | $79.20M(+1.7%) |
| Sep 2002 | - | $77.84M(+12.1%) |
| Jun 2002 | - | $69.42M(+8.9%) |
| Mar 2002 | $63.74M(+6.5%) | $63.74M(-0.6%) |
| Dec 2001 | - | $64.11M(-4.0%) |
| Sep 2001 | - | $66.80M(+8.1%) |
| Jun 2001 | - | $61.80M(+3.3%) |
| Mar 2001 | $59.84M(+1.2%) | $59.84M(+1.2%) |
| Mar 2000 | $59.14M | $59.14M |
FAQ
- What is Haemonetics annual accounts receivable?
- What is the all time high annual accounts receivable for Haemonetics?
- What is Haemonetics annual accounts receivable year-on-year change?
- What is Haemonetics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Haemonetics?
- What is Haemonetics quarterly accounts receivable year-on-year change?
What is Haemonetics annual accounts receivable?
The current annual accounts receivable of HAE is $202.66M
What is the all time high annual accounts receivable for Haemonetics?
Haemonetics all-time high annual accounts receivable is $206.56M
What is Haemonetics annual accounts receivable year-on-year change?
Over the past year, HAE annual accounts receivable has changed by -$3.90M (-1.89%)
What is Haemonetics quarterly accounts receivable?
The current quarterly accounts receivable of HAE is $202.66M
What is the all time high quarterly accounts receivable for Haemonetics?
Haemonetics all-time high quarterly accounts receivable is $213.53M
What is Haemonetics quarterly accounts receivable year-on-year change?
Over the past year, HAE quarterly accounts receivable has changed by -$3.90M (-1.89%)